News
Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on ...
U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II ...
Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug ...
Hosted on MSN1d
Simcere Pharmaceutical Sees Strong Revenue Growth in H1 2025
Simcere Pharmaceutical Group Limited reported a 15.1% increase ... Simcere has established R&D centers in Shanghai, Nanjing, Beijing, Boston, and Hong Kong, and has a robust nationwide marketing ...
Imbria Pharmaceuticals Appoints Physician-Scientist Albert M. Kim, MD, PhD, as Chief Medical Officer
Imbria Pharmaceuticals, Inc., ('Imbria”), a clinical-stage company revolutionizing cardiovascular disease treatment by targeting cardiac energy metabolism, today announced the appointment of physician ...
In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...
As China rises and other global cities aggressively court biotech talent, Massachusetts faces a "contracting moment" that has ...
Bold vision for ancient Chinese garden city could see it evolve into a world-leading biotechnology hub, hosting 10,000 ...
Shorter sleep, going to sleep later and frequent waking during the night all were significantly associated with a 14-year-old ...
AGI Fabricators, a provider of metal structural fabrication solutions, today emphasizes the breadth of its fabrication and ...
"Leaders come to Veeva R&D and Quality Summit eager to share their experiences knowing that new ideas can be the difference in getting needed medicines to patients faster. This openness helps the ...
Drugmakers are investing more in U.S. manufacturing as President Donald Trump threatens tariffs, but facilities can take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results